Iulia C Tudor
Overview
Explore the profile of Iulia C Tudor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
1627
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olawaiye A, Kim J, Bagameri A, Bishop E, Chudecka-Glaz A, Devaux A, et al.
J Gynecol Oncol
. 2024 Jul;
35(4):e111.
PMID: 39032926
Background: Ovarian cancer has the highest mortality among gynecologic cancers, primarily because it typically is diagnosed at a late stage and because of the development of chemoresistance in recurrent disease....
2.
Colombo N, Van Gorp T, Matulonis U, Oaknin A, Grisham R, Fleming G, et al.
J Clin Oncol
. 2023 Jun;
41(30):4779-4789.
PMID: 37364223
Purpose: Despite therapeutic advances, outcomes for patients with platinum-resistant/refractory ovarian cancer remain poor. Selective glucocorticoid receptor modulation with relacorilant may restore chemosensitivity and enhance chemotherapy efficacy. Methods: This three-arm, randomized,...
3.
Wardley A, Cortes J, Provencher L, Miller K, Jo Chien A, Rugo H, et al.
Breast Cancer Res Treat
. 2021 Feb;
187(1):155-165.
PMID: 33591468
Purpose: Androgen receptor (AR) expression occurs in up to 86% of human epidermal growth factor receptor 2-positive (HER2+) breast cancers. In vitro, AR inhibitors enhance antitumor activity of trastuzumab, an...
4.
Litton J, Rugo H, Ettl J, Hurvitz S, Goncalves A, Lee K, et al.
N Engl J Med
. 2018 Aug;
379(8):753-763.
PMID: 30110579
Background: The poly(adenosine diphosphate-ribose) inhibitor talazoparib has shown antitumor activity in patients with advanced breast cancer and germline mutations in BRCA1 and BRCA2 ( BRCA1/2). Methods: We conducted a randomized,...
5.
Szekely A, Levin J, Miao Y, Tudor I, Vuylsteke A, Ofner P, et al.
J Thorac Cardiovasc Surg
. 2011 Apr;
142(2):430-7.e1.
PMID: 21497835
Objective: The roles of perioperative hyperglycemia and diabetes in the risk stratification of patients undergoing coronary artery bypass graft surgery are unclear. The aim of this study is to explore...
6.
Ott E, Mazer C, Tudor I, Shore-Lesserson L, Snyder-Ramos S, Finegan B, et al.
J Thorac Cardiovasc Surg
. 2007 May;
133(5):1242-51.
PMID: 17467436
Objective: In an international, prospective, observational study, we contrasted adverse vascular outcomes among four countries and then assessed practice pattern differences that may have contributed to these outcomes. Methods: A...
7.
Mangano D, Miao Y, Vuylsteke A, Tudor I, Juneja R, Filipescu D, et al.
JAMA
. 2007 Feb;
297(5):471-9.
PMID: 17284697
Context: Acute safety concerns have been raised recently regarding certain hemorrhage-sparing medications commonly used in cardiac surgery. However, no comprehensive data exist regarding their associations with long-term mortality. Objective: To...
8.
Mangano D, Miao Y, Tudor I, Dietzel C
J Am Coll Cardiol
. 2006 Jul;
48(1):206-14.
PMID: 16814669
Objectives: The purpose of this study was to assess the safety and efficacy of the adenosine regulating agent (ARA) acadesine for reducing long-term mortality among patients with post-reperfusion myocardial infarction...
9.
Mangano D, Tudor I, Dietzel C
N Engl J Med
. 2006 Jan;
354(4):353-65.
PMID: 16436767
Background: The majority of patients undergoing surgical treatment for ST-elevation myocardial infarction receive antifibrinolytic therapy to limit blood loss. This approach appears counterintuitive to the accepted medical treatment of the...
10.
Mathew J, Fontes M, Tudor I, Ramsay J, Duke P, Mazer C, et al.
JAMA
. 2004 Apr;
291(14):1720-9.
PMID: 15082699
Context: Atrial fibrillation is a common, but potentially preventable, complication following coronary artery bypass graft (CABG) surgery. Objectives: To assess the nature and consequences of atrial fibrillation after CABG surgery...